Skip to main content
. Author manuscript; available in PMC: 2023 Aug 22.
Published in final edited form as: Mol Pharm. 2022 May 18;19(7):2549–2563. doi: 10.1021/acs.molpharmaceut.2c00260

Figure 4: Response of heterotypic Mia PaCa-2-PCAF 3D cultures to Visudyne®-PDT and PIT.

Figure 4:

Maximum intensity projection (MIP) of fluorescence signals from Mia PaCa-2-PCAF spheroids with different PCAF percentage on day 3 post-PDT. PCAF percentage is mentioned in the top panel (control spheroids PCAF-EGFP panel). Scale bar corresponds to 500 μm.